Thus, we next assessed the effect of each treatment on the inhibition of TGF-β expression in pancreatic tumor tissues and serum of mice following treatment with PBS, gemcitabine, or NK cells. The gene discussed is TGFB1; the disease is pancreatic neoplasm.